Literature DB >> 30258477

Carboplatin-associated Cranial Neuropathy.

Shanlee M Stevens1, Collin M McClelland1, John E Trusheim2, Michael S Lee1.   

Abstract

Carboplatin is a platinum-based chemotherapeutic agent used for the treatment of many solid tumors. Peripheral neuropathy is a common side effect; but, to our knowledge, ocular motor cranial neuropathies have not been reported in the literature. We describe a case of persistent third and fourth nerve palsies after systemic administration of intra-arterial carboplatin for glioblastoma multiforme. Neither nerve regained function after carboplatin was stopped.

Entities:  

Keywords:  Carboplatin; cranial neuropathy; glioblastoma

Year:  2018        PMID: 30258477      PMCID: PMC6152513          DOI: 10.1080/01658107.2017.1419367

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  13 in total

Review 1.  Chemotherapy-induced peripheral neurotoxicity (CIPN): an update.

Authors:  Andreas A Argyriou; Jordi Bruna; Paola Marmiroli; Guido Cavaletti
Journal:  Crit Rev Oncol Hematol       Date:  2011-09-10       Impact factor: 6.312

Review 2.  Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention.

Authors:  Wolfgang Grisold; Guido Cavaletti; Anthony J Windebank
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

Review 3.  The role of intra-arterial chemotherapy as an adjuvant treatment for glioblastoma.

Authors:  Christian Theodotou; Ashish H Shah; Seth Hayes; Amade Bregy; Jeremiah N Johnson; Mohammad A Aziz-Sultan; Ricardo J Komotar
Journal:  Br J Neurosurg       Date:  2014-01-16       Impact factor: 1.596

Review 4.  Platinum-induced neurotoxicity and preventive strategies: past, present, and future.

Authors:  Abolfazl Avan; Tjeerd J Postma; Cecilia Ceresa; Amir Avan; Guido Cavaletti; Elisa Giovannetti; Godefridus J Peters
Journal:  Oncologist       Date:  2015-03-12

Review 5.  Spinal canal metastases: a late complication of glioblastoma.

Authors:  M Schwaninger; S Patt; P Henningsen; D Schmidt
Journal:  J Neurooncol       Date:  1992-01       Impact factor: 4.130

6.  Glioblastoma with spinal seeding.

Authors:  Negar Fakhrai; Thomas Czech; Karin Diekmann; Barbara Fazeny-Dörner; Peter Birner; Johannes A Hainfellner; Daniela Prayer; Christine Marosi
Journal:  Strahlenther Onkol       Date:  2004-07       Impact factor: 3.621

7.  Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experience.

Authors:  Lilyana Angelov; Nancy D Doolittle; Dale F Kraemer; Tali Siegal; Gene H Barnett; David M Peereboom; Glen Stevens; John McGregor; Kristoph Jahnke; Cynthia A Lacy; Nancy A Hedrick; Edna Shalom; Sandra Ference; Susan Bell; Lisa Sorenson; Rose Marie Tyson; Marianne Haluska; Edward A Neuwelt
Journal:  J Clin Oncol       Date:  2009-05-18       Impact factor: 44.544

Review 8.  Cisplatin in cancer therapy: molecular mechanisms of action.

Authors:  Shaloam Dasari; Paul Bernard Tchounwou
Journal:  Eur J Pharmacol       Date:  2014-07-21       Impact factor: 4.432

9.  Bevacizumab-induced transient sixth nerve palsy in ovarian cancer: A case report.

Authors:  Mazdak Momeni; Laura Veras; Konstantin Zakashansky
Journal:  Asia Pac J Clin Oncol       Date:  2013-11-05       Impact factor: 2.601

10.  Neurotoxicity caused by the treatment with platinum analogues.

Authors:  Sousana Amptoulach; Nicolas Tsavaris
Journal:  Chemother Res Pract       Date:  2011-06-27
View more
  1 in total

1.  Isolated Pyridoxine Deficiency Presenting as Peripheral Neuropathy Post-chemotherapy.

Authors:  Aanchal Sawhney; Sachi Singhal; Rahul Patel
Journal:  Cureus       Date:  2022-07-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.